RxSight, Inc. Cash and Restricted Cash
RxSight, Inc. (RXST) had Cash and Restricted Cash of $14.10 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.10M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.32M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.70M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.38M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $14.10M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $18.32M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $20.70M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $30.38M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $41.10M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $28.75M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $17.46M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $17.43M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $25.16M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $33.36M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $10.40M 10-K · filed 2026-02-25 |
| 2023-09-30 | $10.57M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $9.51M 10-Q · filed 2024-08-05 |
| 2023-03-31 | $11.77M 10-Q · filed 2024-05-06 |
| 2022-12-31 | $12.60M 10-K · filed 2026-02-25 |
| 2022-09-30 | $9.72M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $24.82M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $24.94M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $25.17M 10-K · filed 2025-02-25 |
| 2021-09-30 | $68.84M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $42.29M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $24.85M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $14.46M 10-K · filed 2023-03-06 |
| 2020-09-30 | $12.86M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $13.36M 10-Q · filed 2021-09-09 |
| 2019-12-31 | $8.83M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |